Safety and Efficacy of Desferasirox in Chinese Patients With Iron Overload and Aplastic Anemia

Status:
Completed

Trial end date:
2013-11-01

Target enrollment:

Participant gender:

The study is designed to collect safety and efficacy of Desferasirox in Chinese patients with Iron Overload and Aplastic Anemia.

Phase 4

Novartis Pharmaceuticals